BeStock  
Stocks › Biotechnology › LGND

Ligand Pharmaceuticals LGND

US equityMarket cap rank #1897Biotechnology
$286.85 −$0.09 (-0.03%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $286.85 0.00%
Open$285.21
Prev close$286.94
Day range$282.36 – $291.36
Volume259.8K
Market cap$5.74B
P/E (TTM)115.2
Dividend yield–

Analyst view

ConsensusBuy
Analysts8
Average target$367.00+27.9% vs. price
  • Buy 100%
Low $346.00Now $286.85Avg $367.00High $406.00

Recent rating changes

The last 20 actions on file set price targets from $345.00 to $406.00, averaging $371.59.

DateFirmRatingTarget
12 Nov 2026 H.C. Wainwright BUY $358.00
11 Nov 2026 Barclays BUY $350.00
5 Nov 2026 Citi BUY $402.00
1 Nov 2026 RBC Capital BUY $357.00
30 Oct 2026 BofA Securities BUY $406.00
30 Oct 2026 Stifel BUY $350.00
30 Oct 2026 Barclays BUY $345.00
30 Oct 2026 Oppenheimer BUY $346.00
29 Oct 2026 Citi BUY $397.00
29 Oct 2026 H.C. Wainwright BUY $358.00
29 Oct 2026 RBC Capital BUY $357.00
19 Oct 2026 BofA Securities BUY $406.00
25 Sep 2026 Barclays BUY $345.00
24 Sep 2026 Craig-Hallum BUY –
24 Sep 2026 H.C. Wainwright BUY $358.00
23 Sep 2026 Citi BUY $397.00
22 Sep 2026 Craig-Hallum BUY –
22 Sep 2026 BofA Securities BUY $388.00
22 Sep 2026 Stifel BUY –
22 Sep 2026 Citi BUY $397.00

Discussion

No comments yet — be the first to weigh in on LGND.

Sign in to join the discussion.

Scroll to Top